Byline: Will Doss
-
New Migration of Brain Tumor Discovered
A previously unknown migration of glioblastoma may explain why current treatments stall out over time, according to a new study.
-
‘Soft’ Symptoms Detected Before Parkinson’s Disease
People who carry genetic mutations associated with an increased risk for Parkinson’s disease may exhibit minor symptoms long before the disease progresses to affect daily life, according to a study of over 300 patients.
-
Site of Flow Resistance in Glaucoma Identified
According to a recent study, elevated ocular pressure in glaucoma is generated in the wall of a small vessel in the eye, the Schlemm’s canal.
-
New Insights into Cilia Formation
Northwestern Medicine scientists discovered a clever evolutionary quirk in multi-ciliated cells, which help drive fluid flow in a variety of body systems.
-
Gottardi Named Director of Driskill Graduate Program
Cara J. Gottardi, PhD, has been appointed director of the Walter S. and Lucienne Driskill Graduate Program in Life Sciences.
-
2019 in Scientific Images
These images illustrate the physical reality Northwestern scientists work within, striving to uncover the mysteries of biology, chemistry and medicine.
-
Nanoparticle Drug Delivery Could Boost Cancer Therapy
A new lipid nanoparticle drug helped make tumor cells more vulnerable to therapy, significantly prolonging survival in models of glioblastoma.
-
Protein Protects Nucleus from Rupture
A cytoskeletal protein called vimentin helps prevent the nuclei of cells that must navigate through tight spaces in the body from rupturing, according to a recent study.
-
IPHAM Focuses on Chicago Communities
A unified vision for health equity in Chicago was the focus of the second IPHAM Population Health Forum, where scientists and community partners presented and discussed their work in a variety of areas.
-
New Frontiers — in Medicine, and on Campus
Feinberg has had an exceptional year of scientific inquiry, ranging from examining the most basic systems that make our bodies tick to developing breakthrough therapies and treatment strategies.
